Medtronic’s diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut

Investing.com Gold reports: Medtronic’s diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut. This is a premium/paywalled source, so the brief is based on headline and available metadata only.